Ad
related to: amoco invigorate 300 mg capsule brand name
Search results
Results From The WOW.Com Content Network
Testosterone undecanoate; Clinical data; Pronunciation / t ɛ ˈ s t ɒ s t ə r oʊ n ə n ˈ d ɛ k ə n oʊ eɪ t / teh-STOS-tə-rohn ən-DEK-ə-noh-ayt Trade names: Oral: Kyzatrex, Andriol, Jatenzo, Testoheal, others
Major brand names Form Dosage Oral: Testosterone a – Tablet: 400–800 mg/day (in divided doses) Testosterone undecanoate: Andriol, Jatenzo: Capsule: 40–80 mg/2–4× day (with meals) Methyltestosterone b: Android, Metandren, Testred: Tablet: 10–50 mg/day Fluoxymesterone b: Halotestin, Ora-Testryl, Ultandren: Tablet: 5–20 mg/day ...
Amoco (/ ˈ æ m ə k oʊ / AM-ə-koh) is a brand of fuel stations operating in the United States and owned by British conglomerate BP since 1998. The Amoco Corporation was an American chemical and oil company, founded by Standard Oil Company in 1889 around a refinery in Whiting, Indiana, and was officially the Standard Oil Company of Indiana until 1985.
5–20 mg every 2 wks Estradiol benzoate: Progynon-B: Estrogen: IM, SC: 0.5–1.5 mg every 2–3 days Estriol: Ovestin [c] Estrogen: Oral: 4–6 mg/day Spironolactone: Aldactone: Antiandrogen: Oral: 100–400 mg/day Cyproterone acetate: Androcur: Antiandrogen; Progestogen: Oral: 5–100 mg/day Androcur Depot: IM: 300 mg/month Bicalutamide ...
The RESTORE study (Reducing Exacerbations and Symptoms by Treatment with ORal Erdosteine in COPD) was a multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of erdosteine 300 mg/bid added to usual maintenance therapy vs. placebo over 12-months, a period long enough to avoid bias due to seasonal ...
Medroxyprogesterone acetate (Amen, Curretab, Cycrin, Provera) – 2.5 mg, 5 mg, 10 mg Megestrol acetate (Megace) – 20 mg, 40 mg – approved specifically for the treatment of breast and endometrial cancer [ 46 ] and for the treatment of anorexia , cachexia , and weight loss in patients with AIDS Tooltip acquired immunodeficiency syndrome [ 47 ]
The most frequent side effects include headache, insomnia, sleepiness, parkinsonism (effects similar to Parkinson's disease such as shaking, muscle stiffness and slow movement), dystonia (involuntary muscle contractions), tremor (shaking), dizziness, akathisia (restlessness), agitation, anxiety, depression, increased weight, nausea, vomiting, constipation, dyspepsia (heartburn), diarrhea, dry ...
In the UK, it is sold under the brand Heminevrin (AstraZeneca Pharmaceuticals). Other brand names include Nevrin in Romania, Distraneurin in Germany and Distraneurine in Spain. The drug is marketed either as a free base in an oily solution containing 192 mg in capsule form, or as clomethiazole edisylate syrup. Due to its high toxicity compared ...